New Phytologist, Volume 249, Issue 2, Page 975-991, January 2026.Summary Plant‐symbiotic Trichoderma fungi attack microorganisms by secreting antibiotic membrane‐permeabilising peptaibols such as alamethicin. These peptaibols also permeabilise plant root epidermis plasma membranes (PMs), but mild pretreatment with Trichoderma cellulase activates a unique cellulase‐induced resistance to alamethicin (CIRA), via an ...
Saritha Panthapulakkal Narayanan +9 more
wiley +1 more source
Exhalation of Rn-219 by patients treated with Radium-223. [PDF]
EJNMMI PhysWanke C +3 more
europepmc +1 more source
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. [PDF]
Int J Mol Sci, 2023 Suominen MI +10 more
europepmc +1 more source
Prostate cancer – Therapy with radium-223 [PDF]
Revista da Associação Médica Brasileira, 2017 Ana Emília, Brito +4 more
openaire +2 more sources
Radium-223 in metastatic prostate cancer: effects on metastasis microenvironment
, 2019 Nuno Tiago Tavares
openalex +1 more source
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy [PDF]
, 2020 Pete Anderson +7 more
openalex +1 more source
The Necessary Uniformity of Physical Probability
Philosophy and Phenomenological Research, Volume 112, Issue 1, Page 290-306, January 2026.ABSTRACT According to contemporary consensus, physical probabilities may be “non‐uniform”: they need not correspond to a uniform measure over the space of physically possible worlds. Against consensus, I argue that only uniform probabilities connect robustly to long‐run frequencies.
Ezra Rubenstein
wiley +1 more source
Sequencing of Radium-223 and Lutetium-177 Vipivotide Tetraxetan: Maximizing the Benefit of Systemic Targeted Radiation Therapy in Metastatic Castration-Resistant Prostate Cancer. [PDF]
Oncol TherMehr S, Hauke R.
europepmc +1 more source
Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug
HLA, Volume 107, Issue 1, January 2026.ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk +8 more
wiley +1 more source
Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
, 2019 Elba Etchebehere +5 more
openalex +1 more source